Drug-eluting, bare metal stents pose nearly same risk of thrombosis

06/21/2011 | TheHeart.org (Montreal) (free registration)

Reporting final three-year results of the HORIZONS AMI trial in the journal The Lancet, lead researcher Dr. Gregg Stone of Columbia University Medical Center in New York said drug-eluting stents were found to be equally as safe as bare-metal stents long-term when it comes to stent thrombosis. Rates of thrombosis for both types of stents were nearly 5%, which Stone called "very concerning."

View Full Article in:

TheHeart.org (Montreal) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC